1. Home
  2. MDGL vs TPG Comparison

MDGL vs TPG Comparison

Compare MDGL & TPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • TPG
  • Stock Information
  • Founded
  • MDGL 2011
  • TPG 1992
  • Country
  • MDGL United States
  • TPG United States
  • Employees
  • MDGL N/A
  • TPG N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • TPG Investment Managers
  • Sector
  • MDGL Health Care
  • TPG Finance
  • Exchange
  • MDGL Nasdaq
  • TPG Nasdaq
  • Market Cap
  • MDGL 6.1B
  • TPG 6.2B
  • IPO Year
  • MDGL N/A
  • TPG 2022
  • Fundamental
  • Price
  • MDGL $311.14
  • TPG $54.21
  • Analyst Decision
  • MDGL Strong Buy
  • TPG Buy
  • Analyst Count
  • MDGL 9
  • TPG 13
  • Target Price
  • MDGL $420.63
  • TPG $61.67
  • AVG Volume (30 Days)
  • MDGL 283.6K
  • TPG 1.6M
  • Earning Date
  • MDGL 08-06-2025
  • TPG 08-06-2025
  • Dividend Yield
  • MDGL N/A
  • TPG 3.17%
  • EPS Growth
  • MDGL N/A
  • TPG N/A
  • EPS
  • MDGL N/A
  • TPG N/A
  • Revenue
  • MDGL $317,383,000.00
  • TPG $3,710,887,000.00
  • Revenue This Year
  • MDGL $286.17
  • TPG N/A
  • Revenue Next Year
  • MDGL $64.17
  • TPG $23.50
  • P/E Ratio
  • MDGL N/A
  • TPG N/A
  • Revenue Growth
  • MDGL N/A
  • TPG 44.34
  • 52 Week Low
  • MDGL $200.63
  • TPG $37.52
  • 52 Week High
  • MDGL $377.46
  • TPG $72.98
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 58.78
  • TPG 58.36
  • Support Level
  • MDGL $284.02
  • TPG $52.54
  • Resistance Level
  • MDGL $327.59
  • TPG $56.47
  • Average True Range (ATR)
  • MDGL 12.53
  • TPG 1.36
  • MACD
  • MDGL 2.52
  • TPG 0.14
  • Stochastic Oscillator
  • MDGL 67.07
  • TPG 55.34

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About TPG TPG Inc.

TPG Inc is an alternative asset management firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company focuses on large-scale, control-oriented private equity investments.

Share on Social Networks: